BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8638312)

  • 1. [Chlamydia trachomatis].
    Ottesen M
    Ugeskr Laeger; 1996 Feb; 158(6):751-5. PubMed ID: 8638312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chlamydia trachomatis in pregnant women in the county of Vestsjaelland. Prevalence, prevention of perinatal transmission and cost-effectiveness of screening].
    Ottesen M; Sahl I; Herbstman MM; Friis HM; Philipsen T
    Ugeskr Laeger; 1996 Feb; 158(6):756-8. PubMed ID: 8638313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Births and ectopic pregnancies in a large cohort of women tested for Chlamydia trachomatis.
    Bakken IJ; Skjeldestad FE; Lydersen S; Nordbø SA
    Sex Transm Dis; 2007 Oct; 34(10):739-43. PubMed ID: 17479068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics.
    Mayaud P; Grosskurth H; Changalucha J; Todd J; West B; Gabone R; Senkoro K; Rusizoka M; Laga M; Hayes R
    Bull World Health Organ; 1995; 73(5):621-30. PubMed ID: 8846488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
    Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors for Chlamydia trachomatis infection in pregnant women.
    Kadzhaia D; Merabishvili N
    Georgian Med News; 2005 Dec; (129):33-6. PubMed ID: 16444025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population of Amsterdam. Il Over 90% participation and almost 5% prevalence].
    van den Hoek JA; Mulder-Folkerts DK; Coutinho RA; Dukers NH; Buimer M; van Doornum GJ
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):668-72. PubMed ID: 10321299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia trachomatis and ectopic pregnancy: recent epidemiological findings.
    Bakken IJ
    Curr Opin Infect Dis; 2008 Feb; 21(1):77-82. PubMed ID: 18192790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.
    Davies HD; Wang EE
    CMAJ; 1996 Jun; 154(11):1631-44. PubMed ID: 8646651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lack of evidence to support chlamydia infection screening].
    Andersen B; Østergaard L; Olesen F
    Ugeskr Laeger; 2010 Jul; 172(28):2059-61. PubMed ID: 20615375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae genital infections in a publicly funded pregnancy termination clinic: empiric vs. indicated treatment?
    Patel A; Rashid S; Godfrey EM; Panchal H
    Contraception; 2008 Oct; 78(4):328-31. PubMed ID: 18847583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ; Bakker A; Welte R; van Bergen JE; van den Hoek JA; de Jong-van den Berg LT; Jager JC
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2350-4. PubMed ID: 11129971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can a busy abortion service cope with a screen-and-treat policy for Chlamydia trachomatis infection?
    Cameron ST; Stewart S; Sutherland S
    Int J STD AIDS; 2003 Jan; 14(1):50-4. PubMed ID: 12590794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chlamydia trachomatis: should it be systematically be screened or treated? Literature review and cost/benefit estimation in France].
    Henry-Suchet J; Sluzhinska A; Serfaty D
    Contracept Fertil Sex; 1998 Feb; 26(2):151-8. PubMed ID: 9560916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potentials of screening for Chlamydia trachomatis in Hungary: cost-benefit analysis].
    Nyári T; Mészáros G; Deák J; Nagy E; Kovács L
    Orv Hetil; 2000 Jul; 141(27):1511-6. PubMed ID: 10943109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chlamydia trachomatis infection in women seeking termination of pregnancy 1985-2000].
    Bakken IJ; Skjeldestad FE; Nordbø SA
    Tidsskr Nor Laegeforen; 2004 Jun; 124(12):1638-40. PubMed ID: 15229710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of Chlamydia trachomatis testing and chlamydial infection in pregnant women.
    Lawton B; Rose S; Bromhead C; Brown S; MacDonald J; Shepherd J
    N Z Med J; 2004 May; 117(1194):U889. PubMed ID: 15156207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing infective sequelae of abortion.
    Penney GC
    Hum Reprod; 1997 Nov; 12(11 Suppl):107-12. PubMed ID: 9433966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.